About 11,050 results

ALLMedicine™ Ascites Center

Research & Reviews  3,815 results

Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Jan 27th, 2022 - Background Transjugular intrahepatic portosystemic shunt (TIPS) creation is the percutaneous formation of a tract between the hepatic vein and the intrahepatic segment of the portal vein in order to reduce the portal venous pressure. The blood is ...

Transjugular Liver Biopsy

Jan 27th, 2022 - Background Transjugular liver biopsy was first performed in 1970 and is now an accepted method of liver biopsy when the percutaneous technique is contraindicated. [1, 2] Some clinicians have considered this technique to be inferior to the percutan...

Transiently elevated D-dimer levels post-concentrated ascites reinfusion therapy cannot...
The Journal of Obstetrics and Gynaecology Research; Sone K, Taguchi A et. al.

Jan 26th, 2022 - Cell-free and concentrated ascites reinfusion therapy (CART) is useful for treating malignant ascites. We have previously experienced cases with no DVT-PE despite a marked elevation in D-dimer post-CART. In this study, we assessed the changes in t...

Economic evaluation of long-term albumin use in cirrhosis patients from the Mexican hea...
Annals of Hepatology; Moctezuma-Velazquez C, Castro-Narro G et. al.

Jan 26th, 2022 - . Liver Cirrhosis is a major public health issue associated with high morbidity and mortality. The ANSWER trial showed that long-term human albumin (LTA) infusions led to significant reduction of complications and mortality in patients with uncomp...

Quantitative analysis of the MRI features in the differentiation of benign, borderline,...
Journal of Ovarian Research; Xiao F, Zhang L et. al.

Jan 23rd, 2022 - This study aims to investigate the value of the quantitative indicators of MRI in the differential diagnoses of benign, borderline, and malignant epithelial ovarian tumors (EOTs). The study population comprised 477 women with 513 masses who underw...

see more →

Guidelines  6 results

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and...
Hepatology (Baltimore, Md.); Biggins SW, Angeli P et. al.

May 5th, 2021 - Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.|2021|Biggins SW,Angeli P,Garcia-Tsao G,Ginès P,Ling S...

Guidelines on the management of ascites in cirrhosis.
Gut Aithal GP, Palaniyappan N et. al.

Oct 18th, 2020 - The British Society of Gastroenterology in collaboration with British Association for the Study of the Liver has prepared this document. The aim of this guideline is to review and summarise the evidence that guides clinical diagnosis and managemen...

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.
Clinical and Molecular Hepatology;

Jul 12th, 2018 - KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.|2018| ,|therapeutic use,therapeutic use,diagnosis,etiology,metabolism,therapy,therapeutic use,complications,diagnosis,therapy,complications,diagnosis,analysis,

Toxoplasmosis in pregnancy: prevention, screening, and treatment.
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Paquet C, Yudin MH et. al.

Jan 25th, 2013 - One of the major consequences of pregnant women becoming infected by Toxoplasma gondii is vertical transmission to the fetus. Although rare, congenital toxoplasmosis can cause severe neurological or ocular disease (leading to blindness), as well a...

The diagnosis and management of ovarian hyperstimulation syndrome.
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Shmorgun D, Claman P et. al.

Nov 16th, 2011 - To review the clinical aspects of ovarian hyperstimulation syndrome and provide recommendations on its diagnosis and clinical management. These guidelines will assist in the early recognition and management of ovarian hyperstimulation. Early recog...

see more →

Drugs  84 results see all →

Clinicaltrials.gov  168 results

Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal Carcinomatosis

Jan 21st, 2022 - Background: Approximately 15% of gastric adenocarcinoma patients presents with peritoneal carcinomatosis (PC) at the first encounter and is regarded as an unresectable and end-stage disease. The recommended treatment with palliative chemotherapy a...

Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma

Jan 12th, 2022 - Most patients undergoing hepatectomy for hepatocellular carcinoma (HCC) suffer from underlying liver disease and are exposed to the risk of postoperative ascites, with subsequent morbidity, liver and renal failure, the need for specific treatments...

To Compare "Balloon Occluded Thrombolysis" With "Conventional Catheter Directed Thrombolysis" in Thrombotically Occluded DIPSS Stent in Patients of Budd- Chiari Syndrome.

Dec 27th, 2021 - Primary objective: To study the outcome of combined technique of Balloon occluded thrombolysis, Balloon sweeping and maceration of thrombus in Blocked DIPSS stent and compare it with Conventional catheter directed thrombolysis and angioplasty. Sec...

Intraoperative Hemodynamic Management and Postoperative Outcomes in Liver Transplantation

Dec 21st, 2021 - OBJECTIVES: The main objective of this study is to describe and measure the effects of intraoperative hemodynamic management on postoperative outcomes in liver transplantation in Canada. The specific objectives are: To describe the overall inciden...

Assessment of Portal Hypertension With Multiparametric MRI

Dec 20th, 2021 - Liver cirrhosis has been historically classified as a single histopathologic entity, as it is considered to be the latest fibrosis stage; however it is well known that cirrhosis encompasses different degrees of clinical severity. Advanced liver fi...

see more →

News  333 results

Home-Based System Relieves Refractory Ascites in Cirrhosis

Dec 16th, 2021 - A home-based tunneled peritoneal catheter (PeCa) drainage system provided significant relief for patients with refractory ascites who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS). For these patients, the current sta...

Home-based system relieves refractory ascites in cirrhosis
Jim Kling

Dec 15th, 2021 - A home-based tunneled peritoneal catheter (PeCa) drainage system provided significant relief for patients with refractory ascites who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS). For these patients, the current sta.

Chronically Interrupted: The Importance of Communication With Patient and Family During the COVID-19 Pandemic

Dec 10th, 2021 - Case Narrative A 35-year-old woman has worsening alcoholic cirrhosis and repeated admissions for ascites, hepato-renal syndrome, and alcoholic hepatitis. Upon recognition of her grave prognosis, we proceeded with a shared-management approach invol...

Infigratinib Shows Promising Early Activity in FGFR2-Altered Cholangiocarcinoma

Nov 1st, 2021 - The FGFR inhibitor infigratinib (Truseltiq) demonstrated promising clinical activity and a manageable safety profile in previously treated patients with locally advanced or metastatic cholangiocarcinoma whose tumors harbor FGFR2 gene fusions or re...

Maintenance PARP Yields Impressive PFS Benefit in Recurrent, Platinum-Sensitive Ovarian Cancer

Oct 6th, 2021 - The addition of PARP inhibitors, such as olaparib (Lynparza), niraparib (Zejula), and rucaparib (Rubraca), to the maintenance treatment of patients with recurrent platinum-sensitive ovarian cancer has led to significant progression-free survival (...

see more →

Patient Education  14 results see all →